RankingsPricing
  1. JP-listed companies
  2. Carna Biosciences, Inc.
  3. Financials
  4. Common stock and paid-in capital

Carna Biosciences, Inc.JP:4572

Market cap
¥7.7B
P/E ratio
-3.6x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndCommon stock and paid-in capital (Million JPY)YoY (%)
Dec 31, 20248,647+9.39%
Dec 31, 20237,904+21.31%
Dec 31, 20226,516+11.09%
Dec 31, 20215,865+20.46%
Dec 31, 20204,869-40.13%
Dec 31, 20198,133+35.52%
Dec 31, 20186,001+13.85%
Dec 31, 20175,271+7.49%
Dec 31, 20164,904+6.15%
Dec 31, 20154,620+13.44%
Dec 31, 20144,072

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)